Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1881725 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RalA Binding Protein 1 (RALBP1) (N-Term), (AA 42-71) antibody
- Antibody type
- Polyclonal
- Antigen
- This RALBP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 42-71 amino acids from the N-terminal region of human RALBP1.
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification. Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term,AA 42-71
- Antibody clone number
- RB40405
- Vial size
- 400 μL
- Concentration
- 0.5 mg/mL
Submitted references Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis.
RLIP76: a target for kidney cancer therapy.
Regression of prostate cancer xenografts by RLIP76 depletion.
Physiological and pharmacological significance of glutathione-conjugate transport.
Ral-GTPases: approaching their 15 minutes of fame.
Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Rao Lelsani PC, Yadav S, Awasthi S
International journal of cancer. Journal international du cancer 2010 Mar 15;126(6):1327-38
International journal of cancer. Journal international du cancer 2010 Mar 15;126(6):1327-38
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis.
Singhal SS, Yadav S, Vatsyayan R, Chaudhary P, Borvak J, Singhal J, Awasthi S
Cancer letters 2009 Oct 8;283(2):152-8
Cancer letters 2009 Oct 8;283(2):152-8
RLIP76: a target for kidney cancer therapy.
Singhal SS, Singhal J, Yadav S, Sahu M, Awasthi YC, Awasthi S
Cancer research 2009 May 15;69(10):4244-51
Cancer research 2009 May 15;69(10):4244-51
Regression of prostate cancer xenografts by RLIP76 depletion.
Singhal SS, Roth C, Leake K, Singhal J, Yadav S, Awasthi S
Biochemical pharmacology 2009 Mar 15;77(6):1074-83
Biochemical pharmacology 2009 Mar 15;77(6):1074-83
Physiological and pharmacological significance of glutathione-conjugate transport.
Awasthi YC, Chaudhary P, Vatsyayan R, Sharma A, Awasthi S, Sharma R
Journal of toxicology and environmental health. Part B, Critical reviews 2009 Aug;12(7):540-51
Journal of toxicology and environmental health. Part B, Critical reviews 2009 Aug;12(7):540-51
Ral-GTPases: approaching their 15 minutes of fame.
Feig LA
Trends in cell biology 2003 Aug;13(8):419-25
Trends in cell biology 2003 Aug;13(8):419-25
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- RALBP1 Antibody (N-term) (ABIN1881725) western blot analysis in MCF-7 cell line lysates (35 μg/lane). This demonstrates the RALBP1 antibody detected the RALBP1 protein (arrow).
